COMPANY LIST

Business Expansion
on Kobe's Port Island

366

companies

as of November 30, 2019

KOBE Life Science
Cluster Company List

Companies listed in this brochure are participants of the Kobe Medical Industry Development Project and operating on Kobe Port Island. Companies are divided into each categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the miner field.

Search by Company name & Keyword

  • Business
  • Location
  • Initial

Business sector search resultsGenomics

110of Results 22

Re-search in Business sector
  1. 1
  2. 2
  3. 3
  4. >

Location search results

110of Results 22

Re-search in Location
  1. 1
  2. 2
  3. 3
  4. >

You can select the initial.

Initial search results

110of Results 22

Re-search in Initial
  1. 1
  2. 2
  3. 3
  4. >

Aquatech Co., Ltd.

Major field:Medical equipment

Miner field:Regenerative medicine

Miner field:Genomics

Super micro tubing pumps for medical and bio-related fields.

Overview

Aquatech employs 38 people and most of them are retirants of one of the major electronic component manufacturers. Aquatech manufactures unique peristaltic pumps based on their original technology of which trade name is “Ring Pump”. Since It employs very simple mechanism compared with conventional peristaltic pump, it can be designed and made very small is size. Using this advantage, we recently developed super micro peristaltic pumps which are expected to meet the need in medical and bio-industry.

Product / Service / PR

    Micro Ring Pump
     RP-TX: Max flow rate 40μl. Minimum flow rate 0.03μl./min.
     RP-HX: Max flow rate 310μl. Minimum flow rate 25μl./min.
     RP-Q : Max flow rate 450μl. Minimum flow rate 220μl./min.
    Micro Fluidic Controller
     MFC-R01: Max flow rate 140μl. Minimum flow rate 1μl./min.
        Temperature control  0 to 60℃
Address: 2-1-13, Ono, Daito-city, Osaka, Japan  (Contact Person Hisashi Takahashi)
TEL: +81-72-806-3210 FAX: +81-72-806-3211
Web site: http://www.ringpump-aquatech.co.jp E-mail: info@ringpump-aquatech.co.jp

BGI JAPAN K.K.

Major field:Genomics

Miner field:IT

Contracted business and collaborative research of various genome analysis

Overview

BGI, the world’s largest genomics organization, has established BGI JAPAN K.K. in Japan. BGI JAPAN K.K. is engaged in the genomics research and service of human genes, disease, plants and animals, microorganisms, environment and energy. As your premier scientific partner, by the research achievements and the technical know-how obtained in the past ten years, together with the advanced equipments we provide a comprehensive list of genomic solutions to meet your research needs.

Product / Service / PR

    Powered by high through put sequencers platform, we provide reliable, high-quality sequencing results with industry-leading turnaround time. Our high-performance supercomputing facilities and bioinformatics center (with 1000 professionals) provide the hardware and software tools and analysis capabilities to support genomics research studies. We provide reliable technical support across the genome analysis, protein analysis, RNA analysis, epigenetics and genotyping.
Address: Kobe KIMEC Center BLDG.8F,1-5-2 Minatojima-minamimachi,Chuo-ku,KobeCity,Hyogo-pref.650-0047,JAPAN  (Contact Person Sujie Cao)
TEL: +81-78-599-6108 FAX: +81-78-599-6109
Web site: https://www.bgi.com/jp/ E-mail: bgijapan@genomics.cn

Biologics Center for Research and Training

Major field:Other

Miner field:Genomics

Miner field:Regenerative medicine

Development of human resources and provision of support for R&D activities in the field of biologics

Address: Integrated Research Center of Kobe University Annex Bldg. 401 7-1-49 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Japan  (Contact Person Hideo Nogusa)
TEL: 078-302-0123 FAX: 078-599-6087
Web site: https://www.bcret.jp E-mail: hideo.nogusa@bcret.jp

Carna Biosciences, Inc.

Major field:Drug discovery

Miner field:Genomics

Miner field:Contract research

Drug discovery business and drug discovery support business

Overview

Carna Biosciences, Inc. is a biotech company established in April 2003 in Kobe as a spin-off company from Japanese research unit of NV Organon and is listed on Tokyo Stock Exchange JASDAQ Growth.
We conduct research and development to discover novel kinase inhibitors and provide drug discovery supporting services based on the drug discovery platform technology that have been acquired through many years of research and development experiences.

Product / Service / PR

    Carna Biosciences is focused on the discovery and development of kinase inhibitor drugs to treat serious unmet medical needs in oncology, autoimmune and neurological diseases by inhibiting kinases that are important drivers for those diseases.
    Carna Biosciences also provides high quality kinase proteins, accurate screening and profiling services, assay kits and assay development that satisfy customer needs, and cell-based assay services, playing an important role in kinase inhibitor drug discovery conducted by global pharmaceutical companies.
Address: BMA 3F, 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047  (Contact Person Corporate Planning)
TEL: +81-78-302-7039 FAX: +81-78-302-6665
Web site: https://www.carnabio.com/english/ E-mail: ir-team@carnabio.com

Double Helix International, Inc.

Major field:Production equipment

Miner field:Regenerative medicine

Miner field:Genomics

Development of regenerative medicine-related devices

Overview

Double Helix International, Inc. represents major players of single use system manufactures in the US and Europe including but not limited to SaniSure, Inc., AdvantaPure from New Age Industries, Inc., PendoTECH,Inc., UFPTehcnologies, Inc. CharterMedical, Inc.. Cellon, S.A., FabOhio and Terracon Corporation.

Address: IMDA 5th Fl., 1-6-5 Minatojima-Minamimachi, Cyuoh-ku, Kobe 650-0047 Japan  (Contact Person Yukino Kanda)
TEL: +81-78-335-6805 FAX: +81-78-335-6806
Web site: http://www.d-helixintl.com E-mail: info@d-helixintl.com

Epigeneron, Inc.

Major field:Drug discovery

Miner field:Genomics

Miner field:Diagnostic agent and device

Overview

Epigeneron, Inc. was founded in April, 2015, as a start-up bio-venture company from academia. In May, 2018, its research function moved to the Bayer CoLaborator incubation facility in Kobe International Business Center (KIBC) in Port Island, Kobe. We are developing cutting-edge life science technologies and aim to develop drugs against intractable diseases and companion diagnostic systems of molecular targeted drugs in collaboration with pharmaceutical companies.

Product / Service / PR

    1. Locus-specific chromatin immunoprecipitation
    (locus-specific ChIP)
    Locus-specific ChIP enables isolation of specific genomic regions for identification of their associated molecules as potential drug targets for development of novel drugs against intractable diseases.
    2. Oligoribonucleotide interference (ORNi) -PCR
    ORNi-PCR enables easy detection of gene mutations as positive signals with high sensitivity and can be used for development of companion diagnostic tools for molecular targeted drugs.
Address: Tosho Bldg. 8F, 3-8-3 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan  (Contact Person Hodaka Fujii)
TEL: +81-3-3527-2119
Web site: https://epigeneron.com E-mail: info@epigeneron.com

Evec, Inc.

Major field:Genomics

Miner field:Contract research

Miner field:Production of drugs and quasi drugs

Cloning the particular antibody from human peripheral B-cells for development of clinical drug, diagnostic reagent, and for seeking biomarkers.

Overview

Evec, Inc. specializes in the discovery and development of fully human antibody from human peripheral blood B cells. The sensitization process is not needed for our business. According to human phenomena, our products will be high-affinity and also low-immunogenicity.
We have now discovered the visualizing method to detect autoantibodies from individual donor. This might be strong tool for developing diagnostic instrument, next clinical target and biomarkers.

Product / Service / PR

    ・Cloning antibody gene from hybridoma, identification and purification
    ・Class switch of antibody, chimerization and humanization
    ・Antibody generation from particular donors
    ・Potential Evaluation to isolate antibody against particular antigen using our secretome library system
    ・Generation of fully human antibody from peripheral B-cells
    ・Detection of auto-antibody properties from particular donors
    ・Provide the big data of auto-antibody against healthy donors, patients and any kinds of cohorts (Inquiry).
Address: KIBC404, 5-5-2, Minatojima Minamimachi, Chuo-ku, Kobe  (Contact Person Takashi Torashima)
TEL: 011-807-7235 FAX: 011-807-7245
Web site: https://www.evec.jp/ E-mail: support@evec.jp

GSP Lab., Inc.

Major field:Diagnostic agent and device

Miner field:Regenerative medicine

Miner field:Genomics

Development, production, and sales of companion diagnostics

Overview

More than 300 kinds of development of a FISH probe, production and sale are being performed from 200,000 kinds of BAC clone built originally.
The product in which the cancer relation, genetic abnormal of diagnosis preimplantation and regenerative medicine (iPS cell) are detected has been often developed.
These products are also used by foreign countries, not only the country and appear on a paper beyond 120 reports.

Product / Service / PR

    Chromosomal abnormal is detected.
    Amplification and translocate of a cancer related gene are detected.
    The chromosome number-like abnormality of preimplantation cell is detected.
    The chromosome number-like abnormality of ES and iPS cell is detected.
Address: Kobe KIMEC Center Bldg. 6F, 1-5-2Minatojima-Minamimachi Chyo-ku Kobe, Hyogo, 650-0047 Japan  (Contact Person Masahiko Maekawa)
TEL: +81-78-599-8635 FAX: +81-78-599-8636
Web site: http://www.gsplab.co.jp/ E-mail: info@gsplab.co.jp

Ig-M Co.,Ltd. Kobe headquarters

Major field:Regenerative medicine

Miner field:Genomics

Miner field:Experimental animals

R&D in the field of biology and its related business

Overview

Ig-M Co., Ltd. aims to analyze needs in the fields of bio / life science such as medicine / medicine, medical devices, functional products, etc., and form them as “objects”. Our first seeds are the technical ability to obtain reliable basic data, and the second seeds are the ideas and planning powers derived by adding multifaceted evaluations to the accumulated Law date. Based on solid technology, I would like to make efforts to develop cell-related tissue products and medical devices / devices.

Product / Service / PR

    ‣ Cell product development:
      Cellular medicine development and evaluation methods
      Development of tissues (organs) using cells
    ‣ Animal experiments:
      High-spec disease/pathological model creation
      Efficacy test for pharmaceuticals and functional ingredients
    ‣ Animal alternative method: 3D skin RHE test/in vitro test
    ‣ Regenerative medicine:Development using cells and biomaterials
    ‣ Pharmaceuticals/medicine-related:Examination of active
      ingredients/Measurement method
Address: 4-1-1, Minatojima naka-machi, Chuo-ku, Kobe-city, Hyogo, 650-0046, Japan 
Tokyo Branch
3-3-15 Hongo, Bunkyo-ku, Tokyo ,113-0033, Japan 
TEL: +81-78-599-9876 FAX: +81-78-303-5575
Web site: https://www.ig-m.biz E-mail: info@ig-m.biz

KAN RESEARCH INSTITUTE, INC.

Major field:Drug discovery

Miner field:Genomics

Basic research to develop pharmaceutical seeds